APA (7th ed.) Citation

Gumede, N., Bisetty, K., Escuder-Gilabert, L., Medina-Hernandez, M., & Sagrado, S. Prospective evaluation of CYP19A1-mediated aromatase inhibitors for ER+ breast cancers by ultra-high performance liquid chromatography tandem mass spectrometry supported by in silico methods. Elsevier.

Chicago Style (17th ed.) Citation

Gumede, N.J, K. Bisetty, L. Escuder-Gilabert, M.J Medina-Hernandez, and S. Sagrado. Prospective Evaluation of CYP19A1-mediated Aromatase Inhibitors for ER+ Breast Cancers by Ultra-high Performance Liquid Chromatography Tandem Mass Spectrometry Supported by in Silico Methods. Elsevier.

MLA (9th ed.) Citation

Gumede, N.J, et al. Prospective Evaluation of CYP19A1-mediated Aromatase Inhibitors for ER+ Breast Cancers by Ultra-high Performance Liquid Chromatography Tandem Mass Spectrometry Supported by in Silico Methods. Elsevier.